Isoquinoline derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8461329
APP PUB NO 20110288293A1
SERIAL NO

13142230

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAISHO PHARMACEUTICAL CO LTDTOKYO JAPAN TOKYO METROPOLIS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Asanuma, Hajime Tokyo, JP 14 217
Kawamura, Madoka Tokyo, JP 6 47
Koami, Takeshi Tokyo, JP 5 61
Kuroda, Shoichi Tokyo, JP 8 24
Nishikawa, Rie Tokyo, JP 7 26
Oi, Takahiro Tokyo, JP 12 85
Oka, Yusuke Tokyo, JP 22 70
Ono, Naoya Tokyo, JP 29 164
Sekiguchi, Yoshinori Tokyo, JP 23 103
Takayama, Tetsuo Tokyo, JP 20 78
Uneuchi, Fumito Tokyo, JP 5 28
Wakasugi, Daisuke Tokyo, JP 6 20
Yabuuchi, Tetsuya Tokyo, JP 11 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 11, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00